NDC properties for NDC 9 49884-151
NDC item 49884015124
NDC 9 | 49884-151 |
---|---|
NDC 10 | 49884-151-24 |
NDC Item | 49884015124 |
ANDA | ANDA205770 |
COLORTEXT | white(white opaque) |
Color | C48325 __ |
FDA SPL set id | 700460 |
Imprint code | PAR;440 |
Labeler | Par Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
NDC item 49884015154
NDC 9 | 49884-151 |
---|---|
NDC 10 | 49884-151-54 |
NDC Item | 49884015154 |
packaging | 120 CAPSULE in 1 CARTON (49884-151-54) |
ANDA | ANDA205770 |
COLORTEXT | white(white opaque) |
Color | C48325 __ |
FDA SPL set id | 700460 |
Imprint code | PAR;440 |
Labeler | Par Pharmaceutical, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-03-07 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 21 mm |
NDC item 50742028313
NDC 9 | 50742-283 |
---|---|
NDC 10 | 50742-283-13 |
NDC Item | 50742028313 |
packaging | 120 CAPSULE in 1 CARTON (50742-283-13) |
ANDA | ANDA217511 |
COLORTEXT | white(opaque body and a white opaque cap) |
Color | C48325 __ |
FDA SPL set id | 821362 |
Imprint code | ING283 |
Labeler | Ingenus Pharmaceuticals, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-07-04 |
Marketing status | ACTIVE |
Score | 1 |
Shapetext | Hard Gelatin |
Shape | C48336 |
Size | 22 mm |
NDC item 61269038512
NDC 9 | 61269-385 |
---|---|
NDC 10 | 61269-385-12 |
NDC Item | 61269038512 |
packaging | 1 BLISTER PACK in 1 BOX (61269-385-12) / 120 CAPSULE in 1 BLISTER PACK |
COLORTEXT | WHITE(opaque) |
Color | C48325 __ |
FDA SPL set id | 799824 |
Imprint code | Aptalis;BMT |
Labeler | H2-Pharma, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2023-07-31 |
Marketing status | ACTIVE |
NDA | NDA050786 |
Score | 1 |
Shape | C48336 |
Size | 22 mm |